Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Interest & Investment Income (2018 - 2025)

Eton Pharmaceuticals' Interest & Investment Income history spans 4 years, with the latest figure at -$592000.0 for Q3 2025.

  • On a quarterly basis, Interest & Investment Income fell 7300.0% to -$592000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.7 million, a 2519.61% decrease, with the full-year FY2018 number at $164000.0, changed N/A from a year prior.
  • Interest & Investment Income hit -$592000.0 in Q3 2025 for Eton Pharmaceuticals, up from -$1.0 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for ETON hit a ceiling of -$8000.0 in Q3 2024 and a floor of -$1.0 million in Q2 2025.
  • Historically, Interest & Investment Income has averaged -$335111.1 across 3 years, with a median of -$124000.0 in 2023.
  • Biggest five-year swings in Interest & Investment Income: skyrocketed 91.27% in 2024 and later plummeted 9245.45% in 2025.
  • Tracing ETON's Interest & Investment Income over 3 years: stood at -$31000.0 in 2023, then soared by 74.19% to -$8000.0 in 2024, then tumbled by 7300.0% to -$592000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for ETON at -$592000.0 in Q3 2025, -$1.0 million in Q2 2025, and -$1.0 million in Q1 2025.